Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Heart Journal

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AHJ.2004.01.027PMID 15309001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studies.

  2001cited by this paper
• Akuter Myokardinfarkt in Deutschland im Zeitraum zwischen 1996 und 1998: Therapie und hospitaler Verlauf Ergebnisse des Myokardinfarktregisters (MIR) in Deutschland

  1999cited by this paper
• Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarct

  1999cited by this paper
• Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

  1999cited by this paper
• [Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany].

  1999cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• [Early treatment of acute myocardial infarct: implementation of therapy guidelines in routine clinical practice, MITRA pilot phase].

  1997cited by this paper
• Frühbehandlung des akuten Myokardinfarktes: Umsetzung von Therapierichtlinien in den klinischen Alltag, MITRA-Pilotphase

  1997cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

  1996cited by this paper
• One-Year Results From the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) Trial

  1996cited by this paper
• One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators.

  1996cited by this paper
• Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly.

  1996cited by this paper
• Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.

  1994cited by this paper
• Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction.

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

  1994cited by this paper
• A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.

  1993cited by this paper
• The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.

  1993cited by this paper
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.

  1992cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

  1992cited by this paper
• ISIS-3: a randomised comparison of streptokinase vs tPA vs anistreplase and of aspirin plus heparin vs aspirin alone in 41299 cases of suspected myocardial infarction

  1992cited by this paper
• Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study.

  1988cited by this paper
• Aspirin after myocardial infarction.

  1980cited by this paper

• Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK

  2021cites this paper
• Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data

  2020cites this paper
• Dapagliflozin activates AMPK to attenuate cardiac dysfunction and oxidative stress under hypoxia/reoxygenation-caused damage

  2020cites this paper
• Clinical disease registries in acute myocardial infarction.

  2014cites this paper
• Clinical outcome of patients with elevated cardiac markers after percutaneous coronary intervention

  2014cites this paper
• Maximizing Sampling Efficiency

  2013cites this paper
• Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysis.

  2011cites this paper
• Peri-operative management of antiplatelet therapy in patients with coronary artery disease

  2011cites this paper
• A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses?

  2011cites this paper
• Aspirin Use Is Associated With an Improved Long‐Term Survival in an Unselected Population Presenting With Unstable Angina

  2010cites this paper
• Aderenza alla terapia cardioprotettiva nella cardiopatia ischemica

  2009cites this paper
• Impact of combination evidence-based medical therapy on mortality following myocardial infarction in elderly patients.

  2008cites this paper
• Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.

  2007cites this paper
• Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.

  2007cites this paper
• CHAPTER 60 – Aspirin

  2007cites this paper
• Management and in-hospital outcome of patients with first episode of acute myocardial infarction: impact of diabetes mellitus.

  2006cites this paper
• The association between aspirin and blood loss in hip fracture patients.

  2006cites this paper
• [Attitude of district internists to the problem of secondary prevention of ischemic heart disease (results of a special questionnaire survey)].

  2006cites this paper
• Outpatient medication use and health outcomes in post-acute coronary syndrome patients.

  2006cites this paper
• Benefits, challenges, and registerability of the polypill.

  2006cites this paper
• Changes in practice patterns affecting in-hospital and post-discharge survival among ACS patients

  2006cites this paper
• Peri-procedural myocardial injury: 2005 update.

  2005cites this paper
• Are evidence-based cardiovascular prevention therapies being used? A review of aspirin and statin therapies

  2005cites this paper